Acuta Capital Partners, LLC Portfolio Holdings

Acuta Capital Partners, LLC

  • $98.8 Million
  • Q3 2024

Acuta Capital Partners, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $98.8 Million distributed in 41 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Vaxcyte, Inc. with a value of $15.5M, Ocular Therapeutix, Inc with a value of $10.4M, Insmed Inc with a value of $7.85M, Crinetics Pharmaceuticals, Inc. with a value of $6.73M, and Mereo Biopharma Group PLC with a value of $5.18M.

Examining the 13F form we can see an increase of $5.91M in the current position value, from $92.9M to 98.8M.

Acuta Capital Partners, LLC is based out at Belmont, CA

Below you can find more details about Acuta Capital Partners, LLC portfolio as well as his latest detailed transactions.

Portfolio value $98.8 Million
Healthcare: $98.8 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$5.13B
$15.5 Million 15.65% of portfolio
135,400
Q3 2024 Added 22.64%
$654M
$10.4 Million 10.48% of portfolio
1,190,071
Q3 2024 Reduced 57.05%
$9.54B
$7.85 Million 7.94% of portfolio
107,500
Q3 2024 Added 49.1%
$2.88B
$6.73 Million 6.81% of portfolio
131,700
Q3 2024 Reduced 2.55%
$419M
$5.18 Million 5.25% of portfolio
1,260,700
Q3 2024 Added 86.22%
$3.31B
$5.19 Million 5.25% of portfolio
62,100
Q3 2024 Added 47.16%
$3.86B
$4.89 Million 4.95% of portfolio
108,000
Q3 2024 Reduced 18.8%
$89.5M
$4.26 Million 4.31% of portfolio
2,118,992
Q3 2024 Reduced 9.09%
$220M
$4.06 Million 4.11% of portfolio
487,000
Q3 2024 Added 31.88%
$603M
$3.85 Million 3.9% of portfolio
197,000
Q3 2024 Added 20.86%
$71.2M
$3.81 Million 3.86% of portfolio
1,849,402
Q3 2022 Added 20.92%
$875M
$3.51 Million 3.55% of portfolio
190,000
Q3 2024 Reduced 24.11%
$363M
$3.3 Million 3.34% of portfolio
386,500
Q3 2024 New
$34.5B
$3.2 Million 3.24% of portfolio
5,900
Q3 2024 Added 47.5%
$7.61B
$3.14 Million 3.18% of portfolio
21,000
Q3 2024 New
$155M
$2.27 Million 2.3% of portfolio
1,200,000
Q3 2024 Reduced 27.84%
$1.24B
$1.66 Million 1.68% of portfolio
46,200
Q3 2024 Reduced 78.26%
$116B
$1.63 Million 1.65% of portfolio
19,500
Q3 2024 New
$3.1B
$1.39 Million 1.41% of portfolio
25,100
Q3 2024 New
$236M
$970,000 0.98% of portfolio
290,500
Q3 2024 Added 11.73%
$10.2M
$811,000 0.82% of portfolio
1,979,199
Q3 2024 New
$714M
$735,000 0.74% of portfolio
73,500
Q3 2024 New
$344M
$707,000 0.72% of portfolio
146,100
Q3 2024 New
$1.32B
$703,000 0.71% of portfolio
154,900
Q3 2024 New
$186M
$694,000 0.7% of portfolio
46,600
Q3 2024 Added 3.56%
$109M
$274,000 0.28% of portfolio
54,000
Q3 2024 New
$1.1B
$265,000 0.27% of portfolio
19,000
Q3 2024 New
$437M
$210,000 0.21% of portfolio
15,508
Q3 2024 New
Acelyrin Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Artiva Biotherapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Benitec Biopharma Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
-
$0 0.0% of portfolio
-
Q2 2022 New
Leap Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 38.21%
Tourmaline Bio Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 23.17%
Praxis Precision Medicines I
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 65.03%
Tectonic Therapeutic Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Corbus Pharmaceuticals Holdings
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 71.32%
Enliven Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 25.48%
Helix Acquisition Corp Ii
-
$0 0.0% of portfolio
-
Q3 2024 Added 1.75%
Rapport Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 12.0%

Summary

  • Portfolio
  • No. of Stocks 41
  • Current Value $98.8 Million
  • Prior Value $92.9 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 16 stocks
  • Additional Purchases 11 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 12 stocks
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email